|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,200 KRW | +3.33% |
|
-0.65% | +4.25% |
OliX Pharmaceuticals, Inc reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 2,256.75 million compared to KRW 2,328.52 million a year ago. Net loss was KRW 8,503.68 million compared to KRW 9,036.79 million a year ago.
Basic loss per share from continuing operations was KRW 509 compared to KRW 620 a year ago. Basic loss per share was KRW 509 compared to KRW 659 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.25% | 184M | |
| +7.51% | 111B | |
| +11.38% | 106B | |
| -12.61% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.49% | 16.81B | |
| +37.48% | 12.54B | |
| -23.85% | 8.09B |
OLIX PHARMACEUTICALS, INC 